Merck beats quarterly estimates on strength of Keytruda and new products, narrows outlook
Summary
Merck narrowed its 2026 sales guidance and hiked its adjusted profit outlook.
Description
Merck narrowed its 2026 sales guidance and hiked its adjusted profit outlook.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source